Hepatitis/MASH

Individuals with hepatitis C virus genotypes 1 -3 benefitted from treatment with MK-3682B

Reports show that sales and revenue from Hepatitis C treatments are declining. What does this mean for patients?

Two pilot studies are transplanting infected kidneys into patients and then treating them with curative hepatitis C medications.

Zepatier shows promise across genotypes 1 and 4, even among patients administered opioid agonist therapy.

Sofosbuvir adherence in hepatitis C patients impacted by a mental health disease.

Vemlidy treats patients with chronic hepatitis B infection with compensated liver disease.

Vemlidy is a targeted prodrug of tenofovir for chronic hepatitis B infection with compensated liver disease.

Top news of the day from across the health care landscape.

The FDA has approved Vemlidy (tenofovir alafenamide) from Gilead for the treatment of chronic hepatitis B infection with compensated liver disease.

Research evaluates sofosbuvir use in hepatitis C patients with a mental health disease.

Vietnam War veterans are more likely to contract hepatitis C virus than any other veterans, and 65-year-old Joe Benko was no exception to the statistic.

Tenofovir-alafenamide combination approved by the FDA for chronic hepatitis B infection.

A veteran of the Vietnam War recounts the challenges of treatment for hepatitis C virus.

After being denied bail, the Afghani refugee who donned the cover of National Geographic in the 1980s, was rushed to a local hospital in Pakistan.

Phase 2 studies of GS-4997 presented successful results in patients with non-alcoholic steatohepatitis.

HIV positive patients coinfected with hepatitis may face elevated cancer risk.

Vaccine candidates for hepatitis C virus have been notoriously unsuccessful in preventing the infection.

A new trial investigates the use of Lambda in patients with hepatitis D virus.

Parts of a protein used in some HCV vaccine candidates are far too flexible to be successful.

Tennessee pharmacist admits to falsifying prior authorizations, medical lab reports, and drug test results for at least 51 hepatitis C patients prescribed Sovaldi, Harvoni, Viekira Pak, and Daklinza.

A former Clinical Pharmacy Manager at a Walgreens specialty pharmacy pleaded guilty to health care fraud crimes committed between October 2014 and April 2016.

Researchers examine interventions that may improve adherence in chronic viral hepatitis care.

Top articles of the week from The American Journal of Pharmacy Benefits.

Obstacles exist in making testing and treatment for hepatitis C routine practice in prison.

An update of distribution and circulation of HCV genotypes could help reduce disease burden.